Maha Hameed

453 citations
33 papers · 234 indexed · h-index 10
Topics
Chronic Lymphocytic Leukemia Research (5 papers)Diabetes Treatment and Management (3 papers)Lymphoma Diagnosis and Treatment (3 papers)
Journals
Journal of Clinical OncologySHILAP Revista de lepidopterologíaBlood

In The Last Decade

Maha Hameed

28 papers receiving 230 citations

Peers

Maha Hameed
Comparison fields: 5 of 72
  • Cardiology and Cardiovascular Medicine 64
  • Molecular Biology 39
  • Epidemiology 34
  • Pharmacology 33
  • Surgery 28
Replace Ignazio Verzicco with:
Ignazio Verzicco Italy
Gudrun Jonasdottir Sweden
Shuang Zhou China
Ying Cai China
Rebeka Tabbey United States
Yukihide Isogai Japan
Teslime Ayaz Türkiye
Fangkun Yang China
R. A. M. Quax Netherlands
Maha Hameed relative to Ignazio Verzicco Italy Ignazio Verzicco's profile →
Citations per field
00.5×
Ignazio Verzicco · 1×
Citations per year

Countries citing papers authored by Maha Hameed

Since Specialization
Citations

This map shows the geographic impact of Maha Hameed's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maha Hameed with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maha Hameed more than expected).

Fields of papers citing papers by Maha Hameed

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maha Hameed. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maha Hameed. The network helps show where Maha Hameed may publish in the future.

Co-authorship network of co-authors of Maha Hameed

This figure shows the co-authorship network connecting the top 25 collaborators of Maha Hameed. A scholar is included among the top collaborators of Maha Hameed based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maha Hameed. Maha Hameed is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 0
3 1
4 1
5 2
6 35
7 0
8 8
9 4
10 11
11 1
12 1
13 2
14 10
15 14
16 0
17 1
18 9
19 4
20 10

About Maha Hameed

Maha Hameed is a scholar working on Health Informatics, Genetics and Hematology, having authored 33 papers that have together received 234 indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (5 papers), Diabetes Treatment and Management (3 papers) and Lymphoma Diagnosis and Treatment (3 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (64 citations), Health Informatics (3 citations) and Pharmacology (33 citations). Maha Hameed has collaborated with scholars based in United States, India and Saudi Arabia. Frequent co-authors include Vikash Jaiswal, Sakshi Prasad, Vibhor Agrawal, Song Peng Ang, Alessia Gimelli, Jerome Zacks, Helen Huang, Namrata Walia, Angela Ishak and Sneha Annie Sebastian. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026